Top cancer researcher fails to disclose corporate ties in major journals
nytimes.com
nytimes.com
If he had disclosed all his conflicts, the same research would have been published in the same places with the same people. Nothing would have changed. At conferences academic oncologists get up and flash a slide with many conflicts of interest at the start of their talk. Nobody really cares or pays much attention.
When it comes to clinical trials, there are many checks and balances that prevent a 'rogue' conflicted investigator from influencing the results. Not the least of these are the other investigators on the study which put their name on the paper, who are free thinking individuals. The data is also collected and analysed by an independent data monitoring committee, who will for example stop the study early if it is looking futile, whatever the drug company thinks should happen. Independent clinical trial staff will also send out teams to hospitals running the trial and inspect the data and talk to the staff. For trials going for regulatory approval of the drug, there is often a formal independent audit which goes even deeper, to the point of interviewing staff in a confidential setting and asking them if they have been coerced for example.
Speculation.
> Nobody really cares or pays much attention.
Maybe they should.
>When it comes to clinical trials, there are many checks and balances that prevent a 'rogue' conflicted investigator from influencing the results.
And you think these checks and balances work good enough, most of the time?
Clinical trials have standardised designs and procedures, the number of experimental subjects is large (compared to preclinical lab experiments), and orthogonal outcome measures are collected to enhance validity (like response rate and survival outcomes). Most doctors are trained and experienced in interpreting clinical trials, and are well aware of the limitations, which are constantly highlighted in conference discussions and the literature.
Finally, clinical trials are replicated all the time (surprised you would suggest otherwise?). A drug is tested in phase 1, phase 2 and phase 3 trials of increasing size, and drugs from the same class are also tested in competing trials.
Having come from acedemia, I disagree with just about everything in this post. People do care about conflicts of interest and when very powerful people are being reviewed, they get greater leeway because of the power of retribution.
[0] https://www.nytimes.com/2007/06/03/health/03docs.html
[1] https://jamanetwork.com/journals/jama/fullarticle/206127
And then the site just disappeared.
Edit: Maybe https://www.judicialwatch.org/judicial-financial-disclosure/ is a descendant. But damn, they seem rather on the right-wing fringe.
Edit: Found it! It was APBnews.com.[0] And it seems that I was wrong. It apparently just disappeared during 2003-2004.[1] I don't have the patience to trawl through all that, to see what they actually said on their site.
Also, it seems that the National Law Journal has been publishing redacted disclosure data.[2]
0) https://www.rcfp.org/browse-media-law-resources/news-media-l...
1) https://web.archive.org/web/20000101000000*/APBnews.com
2) https://www.rcfp.org/browse-media-law-resources/news/legal-s...
> For years, the evidence has suggested that even small gifts can influence physicians’ behavior, create a mindset of entitlement, and help to promote allegiance to companies and their products. Recently, with the availability of Open Payments data and research made possible by these data, the evidence has become stronger. Using Open Payments data, a 2016 study found that receipt of industry-sponsored meals, even just a single meal, was associated with an increase in the rate of prescribing the brand-name drug that was being promoted.
0) Steinbrook (2017) Physicians, Industry Payments for Food and Beverages, and Drug Prescribing. https://sci-hub.tw/10.1001/jama.2017.2477
We already know certain parts of society need specific protections from other parts of society: professors, journalists, judicial-administrators, etc.
Is it a legitimate extension of that concern that certain parts may, at least in part, need protection from other parts of society?
I mean... leading scientists from schools like Harvard have knowingly lied to the population about the dangers of things like lead, sugar, etc.
> Is it a legitimate extension of that concern that certain parts may, at least in part, need protection from other parts of society?
That's not an extension, it's just a restatement, and not even in different words.
Of course, that is beside the point. One of the most effective treatments remains a series of prolonged dry or water fasts. ~10 and ~40 days respectively. But because no one can patent it or make $3M a year in kickbacks, I doubt it will ever be known to the mainstream in my lifetime.
What are the best sources you have seen to support this? I have seen articles via Google, but I'd like to see more sources. (Writing this comment sitting next to a cancer fighter on a 48-hr chemo session.)
There are clinical trials of fasting in cancer patients. These have been designed by careful and ethical scientists and doctors. They are looking currently at whether fasting can improve the efficacy or tolerance of chemotherapy.
It is frankly stupid to take an already malnourished individual and make them fast for 40 days.
The only times people have not been as successful as others is when fasting was preceded by chemotherapy/radiation which frankly destroy the body and for the most part is a death sentence one way or another.
And you are flat out wrong about your last point. Fasting is the biggest gift you can give your body, including and especially when it appears weaker due to a disease.
Just as you're skeptical of research in the area, I'm skeptical of people claiming to have seen "hundreds of people" cured of diseases by something as simple as fasting.